Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for masi
26.79
-0.77 (-2.79%)
After Hours: 26.78 -0.01 (-0.02%)
Apr 23, 5:11PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.76 - 27.58
52 week 19.47 - 32.20
Open 27.58
Vol / Avg. 264,522.00/358,297.00
Mkt cap 1.52B
P/E 26.39
Div/yield 1.00
EPS 1.02
Shares 56.71M
Beta 0.64
Inst. own 91%
Apr 30, 2014
Q1 2014 Masimo Corporation Earnings Conference Call - 4:30PM EDT - Add to calendar
Apr 30, 2014
Q1 2014 Masimo Corporation Earnings Release - 4:00PM EDT - Add to calendar
Mar 11, 2014
Masimo Corporation at ROTH Conference - Webcast
Mar 4, 2014
Masimo Corporation at Raymond James Financial Inc Institutional Investors Conference - Webcast
Feb 25, 2014
Masimo Corporation at Citi Global Healthcare Conference - Webcast
Feb 13, 2014
Q4 2013 Masimo Corporation Earnings Conference Call - Webcast
Feb 13, 2014
Q4 2013 Masimo Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 6.45% 10.18%
Operating margin 8.88% 14.57%
EBITD margin - 18.12%
Return on average assets 8.50% 13.70%
Return on average equity 11.67% 19.48%
Employees 3,139 -
CDP Score - -

Address

40 PARKER
IRVINE, CA 92618
United States - Map
+1-949-2977000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products. It develops, manufactures and markets a patient monitoring solution that incorporates a monitor or circuit board and sensors, including single-patient use, reusable and ReSposable sensors and patient cables. In addition, it offers remote alarm/monitoring solutions and software. Its Masimo Signal Extraction Technology (Masimo SET) provides capabilities of Measure-Through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Masimo SET has been validated in over 100 independent clinical studies. It offers a remote monitoring and clinician notification solution called the Masimo SafetyNet (SafetyNet), which includes its Masimo SET or rainbow SET monitors at the patient�s bedside along with a central assignment station and wired or wireless server. In March 2012, it acquired Spire Semiconductor, LLC.

Officers and directors

Joe E. Kiani Chairman of the Board, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 49
Bio & Compensation  - Reuters
Rick Fishel President - Worldwide OEM Business and Corporate Development
Age: 55
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President - Operations and Regulatory Affairs, Chief Information Officer
Age: 48
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel
Age: 40
Bio & Compensation  - Reuters
Paul Jansen Executive Vice President - Marketing and Clinical Development
Age: 42
Bio & Compensation  - Reuters
Anand Sampath Executive Vice President - Engineering
Age: 47
Bio & Compensation  - Reuters
Craig B. Reynolds Director
Age: 65
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Independent Director
Age: 68
Bio & Compensation  - Reuters